HORIZONS®
HORIZONS®
Your Pharma Portfolio Instantly Crafted
Welcome to Aharav Consultants, your strategic partner in revolutionising pharmaceutical portfolio management with our premier product suite – HORIZONS®.
In an industry where precision and speed are critical, we recognize the necessity of a solution that not only meets but surpasses your expectations, offering detailed and thorough reports.
What Sets HORIZONS® Apart?
HORIZONS® is more than just a database. It’s a cutting-edge interface designed to perfectly match your company’s unique needs. Save up to 90% of time and 70% of costs on portfolio analysis. Gain actionable insights for swift, efficient decision-making. Here’s why it stands out as the top choice for product selection:
Why HORIZONS®?
Traditional databases often stumble when faced with higher demand to generate instant and accurate information necessary for product selection. This not only affects your time and energy but also efficiency to generate on point results. We have a solution- HORIZONS® – a technology driven game-changer in the field.
Capability Matrix
- Our Testimonial
Client Testimonial
Insitclif at British Generic Manufacturers Association (BGMA)
The HORIZONS® database was very helpful for efficient product portfolio evaluation across markets.The feature of product-level tagging from both commercial and technical perspectives is unique and powerful. It captures quality information from various sources, thereby speeding up the screening and evaluation process. The backend team is very approachable and has been very supportive with training and individual technical support.
Global Portfolio & IP Head at Biocon
The HORIZONS® platform has really helped us see the potential of our products and understand exclusivity dates worldwide, adding value in all our key markets. The team at HORIZONS® has been incredibly supportive and flexible, making sure we got the visualization tools we needed. It's been a great experience overall.
Head & Chief of Staff at Lupin
The BGMA values Aharav Consulting’s support in utilizing HORIZONS® and analyst reports to build an evidence base. We use this evidence to advocate for the savings potential of generics and biosimilars to the government, parliamentarians, and the media.